American Well Corporation

NYSE: AMWL · Real-Time Price · USD
6.25
-1.08 (-14.73%)
At close: May 01, 2025, 3:59 PM
6.65
6.49%
After-hours: May 01, 2025, 07:38 PM EDT

Company Description

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare.

The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings.

Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.

The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks.

American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

American Well Corporation
American Well Corporation logo
Country United States
IPO Date Sep 17, 2020
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 877
CEO Dr. Ido Schoenberg M.D.

Contact Details

Address:
75 State Street
Boston, Massachusetts
United States
Website https://amwell.com

Stock Details

Ticker Symbol AMWL
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001393584
CUSIP Number 03044L204
ISIN Number US03044L2043
Employer ID 00-0000000
SIC Code 7389

Key Executives

Name Position
Dr. Ido Schoenberg M.D. Chairman & Chief Executive Officer
Amber Howe Chief People Officer
Anna Nesterova Head of Legal
Dan Zamansky Chief Product & Technology Officer
Dr. Cynthia Horner FAAFP, M.D. Chief Medical Officer & President of Amwell Medical Group
Dr. Roy Schoenberg M.D., M.P.H. Executive Vice Chairman
Paul Francis McNeice Vice President of Accounting
Phyllis I. Gotlib President of Amwell International
Sue Dooley Head of Investor Relations

Latest SEC Filings

Date Type Title
Apr 23, 2025 ARS Filing
Apr 23, 2025 DEFA14A Filing
Apr 23, 2025 DEF 14A Filing
Apr 03, 2025 4 Filing
Apr 03, 2025 4 Filing
Mar 10, 2025 4 Filing
Mar 10, 2025 3 Filing
Mar 05, 2025 4 Filing
Mar 05, 2025 4 Filing
Mar 03, 2025 8-K Current Report